Sanofi | SNY - Ebitda




Sanofi reported EUR4.49B in EBITDA for its fiscal quarter ending in September of 2024.

Ebitda Change Date
AbbVie USD 6.03B 1.03B Sep/2024
Amgen USD 2.93B 517M Dec/2024
AstraZeneca USD 5.26B 597M Dec/2024
Bristol-Myers Squibb USD 4.73B 48M Dec/2024
Canopy Growth CAD -10728000 80.1M Sep/2024
Corcept Therapeutics USD 47.1M 11.31M Sep/2024
Drreddys Laboratories INR 21.91B 294M Sep/2024
Eli Lilly USD 4.9B 786M Sep/2024
Galapagos EUR -48446000 52.4M Sep/2024
Genmab DKK 2.23B 85M Sep/2024
GlaxoSmithKline GBP 2.08B 1.22B Dec/2024
Glaxosmithkline GBP 1.17B 1.79B Sep/2024
Indivior 9M 92M Sep/2024
J&J USD 5.27B 109M Dec/2024
Merck USD 6.07B 1.38B Sep/2024
Novartis USD 5.19B 319M Dec/2024
Novartis USD 5.61B 310M Sep/2024
Pacira USD -114754000 173.32M Sep/2024
Perrigo USD 195.7M 143.7M Sep/2024
Pfizer USD 4.26B 2.59B Dec/2024
Prestige Brands USD 98.83M 6.56M Dec/2024
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.25B 2.22B Sep/2024
Sanofi EUR 4.49B 2.47B Sep/2024
Supernus Pharmaceuticals USD 65.04M 18.02M Sep/2024
UCB EUR 652M 105M Jun/2024
Zoetis USD 822M 217M Dec/2024